Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
Premaitha Health brings IONA test to Egypt, a country with 2.8 million new born babies every year
February 16, 2018 Off

Premaitha Health brings IONA test to Egypt, a country with 2.8 million new born babies every year

By Dino Mustafić

Premaitha Health has signed an agreement to offer the IONA test across Egypt. As a result of, Premaitha has secured…

Canada allows combination of Janssen’s Zytiga with ADT in to treat certain prostate cancer (mHSPC)
February 16, 2018 Off

Canada allows combination of Janssen’s Zytiga with ADT in to treat certain prostate cancer (mHSPC)

By Dino Mustafić

Johnson & Johnson’s Janssen has welcomed the news from Health Canada as it got approval to use Zytiga combined with prednisone…

Accelerate Diagnostics doubles quarter revenue, posts net loss of $15.1 million. Focus on revenue in 2018
February 15, 2018 Off

Accelerate Diagnostics doubles quarter revenue, posts net loss of $15.1 million. Focus on revenue in 2018

By Dino Mustafić

Accelerate Diagnostics has doubled its revenues in the last quarter of 2017 compared to the last year’s same period. The…

Akcea could have first therapy for people with familial chylomicronemia syndrome in August
February 15, 2018 Off

Akcea could have first therapy for people with familial chylomicronemia syndrome in August

By Dino Mustafić

Akcea Therapeutics will be waiting August 2018, and expecting affirmation from FDA’s Metabolism and Endocrinology division for its treatment against…

FDA allows marketing of first blood test to aid in the evaluation of concussion in adults
February 15, 2018 Off

FDA allows marketing of first blood test to aid in the evaluation of concussion in adults

By Dino Mustafić

The U.S. Food and Drug Administration has allowed of the first blood test to evaluate mild traumatic brain injury (mTBI),…

Selumetinib granted Orphan Drug Designation by the US FDA for neurofibromatosis type 1
February 15, 2018 Off

Selumetinib granted Orphan Drug Designation by the US FDA for neurofibromatosis type 1

By Dino Mustafić

AstraZeneca and Merck will have a new Orphan Drug Designation in selumetinib, a MEK 1/2 inhibitor, as the US Food and…

Bormioli Pharma offers solution to unstable drug formulations
February 15, 2018 Off

Bormioli Pharma offers solution to unstable drug formulations

By Dino Mustafić

This year’s Pharmapack Conference  saw Bormioli Pharma, one of the world’s leading glass and plastic packaging manufacturers for the pharmaceutical sector, make a…

FDA approves Janssen’s prostate cancer drug
February 15, 2018 Off

FDA approves Janssen’s prostate cancer drug

By Dino Mustafić

The U.S. Food and Drug Administration has approved  Janssen Pharmaceutical  ‘sErleada (apalutamide) for the treatment of patients with prostate cancer that has…

Celgene’s Otezla better than placebo in a phase 2 test
February 15, 2018 Off

Celgene’s Otezla better than placebo in a phase 2 test

By Dino Mustafić

Celgene Corporation said that a higher proportion of patients taking apremilast 30 mg twice daily (BID) achieved clinical remission versus placebo.…

BASF joins the World Plastics Council
February 15, 2018 Off

BASF joins the World Plastics Council

By Dino Mustafić

BASF ahs joined the World Plastics Council (WPC), a global organization of key leaders in the plastics industry. The WPC…

Posts pagination

Previous 1 … 3,404 3,405 3,406 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine